EGFR and central nervous system cancer: Amplification of EGFR is the most common genetic alteration that occurs in glioblastoma, and glioblastoma shows that amplified EGFR commonly overexpresses the receptor variant III (EGFRvIII), which indicates the importance of EGFRvIII in the case of elevated proliferation of glioma cells [32].